Olestra is a fat substitute approved by the FDA for use in snack foods. To
investigate reports of gastrointestinal problems associated with olestra
consumption, an experiment was carried out to compare olestra potato chips
with regular potato chips ("Gastrointestinal Symptoms Following Consumption of
Olestra or Regular Triglyceride Potato Chips," Journal of the American Medical
Association \([1998]: 150-152\) ). Subjects were assigned at random to either
the olestra chip group or the regular chip group. Of the 529 individuals in
the regular chip group, 93 experienced gastrointestinal symptoms, whereas 90
of the 563 individuals in the olestra chip group experienced symptoms. Carry
out a hypothesis test at the \(5 \%\) significance level to decide whether the
proportion of individuals who experience symptoms after consuming olestra
chips differs from the proportion who experience symptoms after consuming
regular chips.